Neola Medical Past Earnings Performance
Past criteria checks 0/6
Neola Medical's earnings have been declining at an average annual rate of -18.1%, while the Medical Equipment industry saw earnings growing at 21.2% annually. Revenues have been growing at an average rate of 24.6% per year.
Key information
-18.1%
Earnings growth rate
24.9%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 24.6% |
| Return on equity | -13.1% |
| Net Margin | -85.0% |
| Next Earnings Update | 12 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Neola Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 11 | -9 | 18 | 0 |
| 30 Jun 24 | 11 | -9 | 18 | 0 |
| 31 Mar 24 | 11 | -9 | 17 | 0 |
| 31 Dec 23 | 10 | -9 | 16 | 0 |
| 30 Sep 23 | 9 | -10 | 16 | 0 |
| 30 Jun 23 | 9 | -10 | 16 | 0 |
| 31 Mar 23 | 9 | -10 | 17 | 0 |
| 31 Dec 22 | 10 | -10 | 18 | 0 |
| 30 Sep 22 | 11 | -9 | 18 | 0 |
| 30 Jun 22 | 12 | -8 | 18 | 0 |
| 31 Mar 22 | 13 | -7 | 17 | 0 |
| 31 Dec 21 | 11 | -7 | 16 | 0 |
| 30 Sep 21 | 8 | -7 | 14 | 0 |
| 30 Jun 21 | 6 | -9 | 14 | 0 |
| 31 Mar 21 | 4 | -8 | 11 | 0 |
| 31 Dec 20 | 3 | -7 | 9 | 0 |
| 30 Sep 20 | 3 | -6 | 8 | 0 |
| 30 Jun 20 | 3 | -3 | 6 | 0 |
| 31 Mar 20 | 3 | -3 | 6 | 0 |
| 31 Dec 19 | 3 | -3 | 5 | 0 |
| 31 Dec 18 | 3 | -1 | 4 | 0 |
Quality Earnings: NEOLA is currently unprofitable.
Growing Profit Margin: NEOLA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEOLA is unprofitable, and losses have increased over the past 5 years at a rate of 18.1% per year.
Accelerating Growth: Unable to compare NEOLA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NEOLA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).
Return on Equity
High ROE: NEOLA has a negative Return on Equity (-13.12%), as it is currently unprofitable.